Veradermics MANE
NYSE MANE
$136.90 +9.79 (+7.70%)
As of: Oct 21, 2026 · 3:59 PM EDT

Veradermics (MANE) Ending Cash Balance (2024 - 2026)

Updated

Analysis

Veradermics (MANE) Ending Cash Balance (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Ending Cash Balance (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 20.42 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 6.57 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 6.89 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 4.88 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 3.18 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 1.03 Bn
10 Veradermics 5.53 Bn 4.13 Bn - 319.33 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 319.33 Mn
Mar 31, 2026 168.41 Mn
Dec 31, 2025 21.77 Mn
Jun 30, 2025 8.60 Mn
Mar 31, 2025 32.44 Mn
Dec 31, 2024 53.08 Mn
API Access

Veradermics Ending Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=MANE&period=max&api_key=YOUR_API_KEY